- Directors and Auditors
- Articles of Association
- General Meetings
- - Previous General Meetings
- Insider Trading
Dignitana hires Johan Johansson to Head Operations, Research and Development
Dignitana has named Johan Johansson as Vice President of Operations, Research and Development. He begins the role immediately at the Company’s headquarters in Lund.
“Johan brings not only proven success in Operations, Research and Development, but also specific experience with devices for temperature management as well as side effects of chemotherapy. This expertise aligns well with our strategic goals and Johan is a valuable addition to our management team,” said Dignitana CEO Catarina Mård Löwenadler.
Most recently Johansson worked at Additude AB supporting all stages of medical device development including medical device regulation and regulatory compliance. Previously he oversaw the development of three medical devices as Chief Technical Officer at BrainCool AB, which was a subsidiary of Dignitana AB until 2014. Prior to BrainCool, Johansson held various roles in Engineering, Research and Development at Baxter, Krohne and Gambro.
Johansson holds a Master of Science in Engineering from Lund University.
Dignitana Chairman of the Board Klas Arildsson had been serving as Interim Chief Operations Officer for the Company. With the addition of Johan Johansson to the Company, the COO assignment for Klas Arildsson has ended.
For More Information Contact
Melissa Bourestom, Chief Communications Officer, email@example.com +1 469-518-5031
Dignitana AB is the world leader in clinically superior scalp cooling technology. The company produces The DigniCap® Scalp Cooling System, a patented medical cooling device that offers cancer patients the ability to minimize hair loss during chemotherapy. FDA cleared since 2015, DigniCap provides continuous cooling with high efficacy, safety and patient comfort. Hailed internationally as a life-changing medical advancement for cancer patients, The DigniCap Scalp Cooling System was invented in 1999 by a Swedish Oncology nurse and has been available in Europe since 2001. Dignitana AB is listed on Nasdaq First North Growth Market in Sweden with headquarters in Lund, Sweden and US operations based in Dallas, Texas in the United States. Company subsidiaries are Dignitana, Inc. in the United States and Dignitana S.r.l. in Italy. Certified Adviser is Redeye AB. Learn more at www.dignitana.com or www.dignicap.com.